Lee JI - Search Results

1

New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.

Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, Chung S, Colangelo P, Frucht D, Green MD, Hepp P, Karnaukhova E, Ko HS, Lee JI, Marroum PJ, Norden JM, Qiu W, Rahman A, Sobel S, Stifano T, Thummel K, Wei XX, Yasuda S, Zheng JH, Zhao H, Lesko LJ. Huang SM, et al. Among authors: lee ji. J Clin Pharmacol. 2008 Jun;48(6):662-70. doi: 10.1177/0091270007312153. Epub 2008 Mar 31. J Clin Pharmacol. 2008. PMID: 18378963 Review.

2

CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications.

Lee JI, Zhang L, Men AY, Kenna LA, Huang SM. Lee JI, et al. Clin Pharmacokinet. 2010 May;49(5):295-310. doi: 10.2165/11319980-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20384392 Review.

3

Nuclear factor kappa B: important transcription factor and therapeutic target.

Lee JI, Burckart GJ. Lee JI, et al. J Clin Pharmacol. 1998 Nov;38(11):981-93. doi: 10.1177/009127009803801101. J Clin Pharmacol. 1998. PMID: 9824778 Review.

4

Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B.

Lee JI, Ganster RW, Geller DA, Burckart GJ, Thomson AW, Lu L. Lee JI, et al. Transplantation. 1999 Nov 15;68(9):1255-63. doi: 10.1097/00007890-199911150-00007. Transplantation. 1999. PMID: 10573060

5

Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.

Lee JI, Chaves-Gnecco D, Amico JA, Kroboth PD, Wilson JW, Frye RF. Lee JI, et al. Clin Pharmacol Ther. 2002 Dec;72(6):718-28. doi: 10.1067/mcp.2002.129068. Clin Pharmacol Ther. 2002. PMID: 12496753 Clinical Trial.

6

Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes.

Liu X, LeCluyse EL, Brouwer KR, Lightfoot RM, Lee JI, Brouwer KL. Liu X, et al. Among authors: lee ji. J Pharmacol Exp Ther. 1999 Jun;289(3):1592-9. J Pharmacol Exp Ther. 1999. PMID: 10336557

7

Swd2/Cps35 determines H3K4 tri-methylation via interactions with Set1 and Rad6.

Oh J, Park S, Kim J, Yeom S, Lee JM, Lee EJ, Cho YJ, Lee JS. Oh J, et al. BMC Biol. 2024 May 3;22(1):105. doi: 10.1186/s12915-024-01903-3. BMC Biol. 2024. PMID: 38702628

8

Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.

Kim DH, Hong J, Shin DY, Kim I, Yoon SS, Bang SM, Lee JO, Lee JY, Kim SA, Byun JM, Koh Y. Kim DH, et al. Br J Haematol. 2024 May 3. doi: 10.1111/bjh.19500. Online ahead of print. Br J Haematol. 2024. PMID: 38699798 No abstract available.

9

A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus.

Lee JH, Kim JW, Lee HE, Song JY, Cho AH, Hwang JH, Heo K, Lee S. Lee JH, et al. Virus Res. 2024 Apr 30:199383. doi: 10.1016/j.virusres.2024.199383. Online ahead of print. Virus Res. 2024. PMID: 38697296

10

MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer.

Kim S, Lee KW, Yoo Y, Park SH, Lee JW, Jeon S, Illia S, Joshi P, Park HW, Lo HE, Seo J, Kim Y, Chang M, Lee TJ, Seo JB, Kim SH, Croce CM, Kim I, Suh SS, Jeon YJ. Kim S, et al. Anim Cells Syst (Seoul). 2024 Apr 30;28(1):184-197. doi: 10.1080/19768354.2024.2345644. eCollection 2024. Anim Cells Syst (Seoul). 2024. PMID: 38693921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,992 results

Search Page